Related Experiment Video
Updated: Aug 30, 2026
LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy
1University of Melbourne Department of Medicine (Dermatology) Australia.
Abstract:
Several studies have reported the efficacy of photodynamic therapy (PDT) in the treatment of non-melanoma skin cancer (NMSC) and pre-cursor lesions, such as actinic keratosis (AK). Recent studies investigating the use of methyl aminolevulinate (MAL, Metvix PDT have made comparisons to existing standard treatments for basal cell carcinoma (BCC) and AK in terms of efficacy, adverse events and cosmetic outcome. This review considers these studies as a body of evidence that supports the use of MAL PDT over traditional therapies in these conditions. The data thus far show PDT to be superior to cryotherapy, 5-fluorouracil (5FU) and excisional surgery in terms of cosmetic outcome, and equivalent in efficacy to other treatment modalities in managing AK and BCC. The studies also show an advantage in the treatment of extensive lesions.
Insights
Photodynamic therapy (PDT) using methyl aminolevulinate (MAL) offers superior cosmetic outcomes for non-melanoma skin cancer and actinic keratosis compared to traditional treatments. It is equally effective and advantageous for extensive lesions.
Area of Science:
- Dermatology
- Oncology
- Photomedicine
Background:
- Non-melanoma skin cancer (NMSC) and actinic keratosis (AK) are common skin conditions.
- Photodynamic therapy (PDT) is an emerging treatment modality.
- Methyl aminolevulinate (MAL) is a photosensitizer used in PDT.
Purpose of the Study:
- To review and synthesize evidence comparing MAL PDT with standard treatments for NMSC and AK.
- To evaluate efficacy, adverse events, and cosmetic outcomes of MAL PDT.
- To assess the suitability of MAL PDT for extensive lesions.
Main Methods:
- Systematic review of recent studies comparing MAL PDT to cryotherapy, 5-fluorouracil (5FU), and excisional surgery.
- Analysis of data on treatment efficacy, patient-reported adverse events, and cosmetic results.
- Evaluation of treatment outcomes for various lesion sizes, including extensive ones.
Main Results:
- MAL PDT demonstrates superior cosmetic outcomes compared to cryotherapy, 5FU, and excisional surgery.
- The efficacy of MAL PDT is equivalent to other standard treatment modalities for AK and basal cell carcinoma (BCC).
- MAL PDT shows an advantage in treating extensive skin lesions.
Conclusions:
- MAL PDT is a favorable treatment option for NMSC and AK, offering comparable efficacy with improved cosmetic results.
- The evidence supports the use of MAL PDT over traditional therapies, particularly for extensive skin conditions.
- Further research may solidify MAL PDT's role as a first-line treatment in dermatology.